The supplement directory

A creamy, low-caffeine (45 mg) instant coffee with collagen and L-theanine; its chaga and lion's mane sit inside a 7.3 g proprietary blend.

Three branded extracts (lemon, saffron, red orange) at their studied doses and cleanly tested. But the trials are small, it's no GLP-1 drug, and it costs $80 a month.

A cheaper AG1 alternative with 7.3 g of organic greens and 5 billion CFU of named probiotics, but a January 2026 Class I Salmonella recall weighs heavily on trust.

A smooth, low-caffeine (48 mg) organic mushroom coffee that went viral, but its 2 g six-mushroom blend is far below doses used in research.

Onnit's Joe Rogan-backed, caffeine-free nootropic; most ingredients sit in three proprietary blends, and the doses that are disclosed are small.

A USDA Organic fruit-and-vegetable powder sold on an aging study that did not show clear benefits; pleasant flavors, but about $3 a scoop with unquantified blends.

A pricey 2 oz nootropic shot with 55 mg caffeine and 10+ adaptogens, but its actives sit in an undisclosed 11.7 g blend and it costs about $5 a shot.

Social media's favorite debloat capsule: ginger plus a proprietary herb and bromelain blend. Clean and tested, but the evidence is thin and it costs about $1.70 a dose.

The viral ACV gummy tastes good and is easy to take, but it doesn't disclose acetic acid, weight-loss evidence is weak, and six a day adds 12 g of sugar.

A novel Akkermansia, C. butyricum and B. infantis probiotic sold on the GLP-1 buzz. It contains no GLP-1, has no human appetite trial and costs $64–89 a month.

A high-caffeine fat burner (265 mg per serving, up to 530 mg a day) with yohimbe and green coffee. Weak weight-loss evidence and a history of liver-injury cases.